SOAT1 and prostate cancer: The over-expression of SOAT1 has been recognized as an indicator of tumor progression in glioblastoma, pancreatic cancer, and prostate cancer [68–70].The high expression of SOAT1 was positively correlated with poor prognosis of HCC patients [71].